AI
By
Can HekaBio and Alfresa’s AI-Driven Alliance Redefine Japan’s Biopharma Access and Launch Asia’s Next AI Commercialization Engine?
Smart Partnerships: HekaBio Leverages Alfresa’s Scale to Localize Global InnovationJapan’s historically delayed access to global therapies may soon…
China focus: Is AstraZeneca’s $5.3B AI-Powered Alliance with CSPC the New Gold Standard in Chronic Disease Drug Discovery?
Key Takeaways: AI as the Catalyst: CSPC’s Dual-Engine Platform Front and CenterAt the core of this partnership lies…
Can Ellipsis Health’s $45M Series A and Launch of ‘Sage’ Redefine AI-Driven Care Management in U.S. Healthcare?
Key Insights: Sage Redefines AI Care Management with Empathy at the CoreEllipsis Health is introducing Sage, an emotionally…
How Tempus AI and Northwestern Use AI to Unlock the Genomic Code of Alzheimer’s? A New Collaboration Targets Precision Breakthroughs
Key Takeaways Transforming Alzheimer’s Research with AI and Precision GenomicsIn a multi-year collaboration announced today, Tempus AI (NASDAQ:…
Can Google DeepMind’s Isomorphic Labs Revolutionize Clinical Trials with AI-Designed Drugs Backed by $600M and AlphaFold Breakthrough?
Key Takeaways AI to Clinic: Isomorphic Labs Moves Beyond Design to Human TrialsIsomorphic Labs, the AI drug discovery…
Five Breakthrough AI Innovations Set to Transform Healthcare in 2025
The healthcare industry is poised for a major transformation in 2025 as artificial intelligence (AI) technologies continue to…
